Concert Pharmaceuticals CNCE
$ 8.37
0.0%
Quarterly report 2022-Q3
added 11-07-2022
Concert Pharmaceuticals EV/EBITDA Ratio 2011-2024 | CNCE
Annual EV/EBITDA Ratio Concert Pharmaceuticals
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-0.193 | -3.46 | -2.61 | -5.81 | 4.79 | -3.14 | 9.01 | -6.86 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
9.01 | -6.86 | -1.03 |